Discovery of pyrazol-3-ylamino pyrazines as novel JAK2 inhibitors
摘要:
The design, synthesis and biological evaluation of a series of pyrazol-3-ylamino pyrazines as potent and selective JAK2 kinase inhibitors is reported, along with the pharmacokinetic and pharmacodynamic properties of lead compounds. (C) 2009 Elsevier Ltd. All rights reserved.
Synthesis of 3,6-Dibromopyrazine-2,5-dicarbonitrile [1]
摘要:
AbstractSymmetrically functionalized pyrazine of 3,6‐dibromopyrazine‐2,5‐dicarbonitrile was synthesized in three or four steps from 3‐aminopyrazinecarbonitrile or its 6‐bromo derivatives.
Discovery of pyrazol-3-ylamino pyrazines as novel JAK2 inhibitors
作者:Stephanos Ioannidis、Michelle L. Lamb、Audrey M. Davies、Lynsie Almeida、Mei Su、Geraldine Bebernitz、Minwei Ye、Kirsten Bell、Marat Alimzhanov、Michael Zinda
DOI:10.1016/j.bmcl.2009.10.054
日期:2009.12
The design, synthesis and biological evaluation of a series of pyrazol-3-ylamino pyrazines as potent and selective JAK2 kinase inhibitors is reported, along with the pharmacokinetic and pharmacodynamic properties of lead compounds. (C) 2009 Elsevier Ltd. All rights reserved.
Synthesis of 3,6-Dibromopyrazine-2,5-dicarbonitrile [1]
作者:Nobuhiro Sato、Shunsuke Fukuya
DOI:10.1002/jhet.797
日期:2012.5
AbstractSymmetrically functionalized pyrazine of 3,6‐dibromopyrazine‐2,5‐dicarbonitrile was synthesized in three or four steps from 3‐aminopyrazinecarbonitrile or its 6‐bromo derivatives.